- Home
- AGRO vs COGT Comparison
AGRO vs COGT Comparison
Compare AGRO & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRO
- COGT
- Stock Information
- Founded
- AGRO 2002
- COGT 2014
- Country
- AGRO Luxembourg
- COGT United States
- Employees
- AGRO N/A
- COGT N/A
- Industry
- AGRO Farming/Seeds/Milling
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- AGRO Consumer Staples
- COGT Health Care
- Exchange
- AGRO Nasdaq
- COGT Nasdaq
- Market Cap
- AGRO 919.9M
- COGT 1.1B
- IPO Year
- AGRO 2011
- COGT 2018
- Fundamental
- Price
- AGRO $9.23
- COGT $11.98
- Analyst Decision
- AGRO Hold
- COGT Strong Buy
- Analyst Count
- AGRO 4
- COGT 9
- Target Price
- AGRO $11.48
- COGT $20.25
- AVG Volume (30 Days)
- AGRO 339.5K
- COGT 1.9M
- Earning Date
- AGRO 08-18-2025
- COGT 08-05-2025
- Dividend Yield
- AGRO 3.71%
- COGT N/A
- EPS Growth
- AGRO N/A
- COGT N/A
- EPS
- AGRO 0.62
- COGT N/A
- Revenue
- AGRO $1,582,638,000.00
- COGT N/A
- Revenue This Year
- AGRO N/A
- COGT N/A
- Revenue Next Year
- AGRO $1.26
- COGT N/A
- P/E Ratio
- AGRO $14.78
- COGT N/A
- Revenue Growth
- AGRO 20.41
- COGT N/A
- 52 Week Low
- AGRO $8.45
- COGT $3.72
- 52 Week High
- AGRO $12.08
- COGT $12.97
- Technical
- Relative Strength Index (RSI)
- AGRO 50.36
- COGT 64.22
- Support Level
- AGRO $9.06
- COGT $10.38
- Resistance Level
- AGRO $9.29
- COGT $11.24
- Average True Range (ATR)
- AGRO 0.17
- COGT 0.54
- MACD
- AGRO 0.00
- COGT -0.19
- Stochastic Oscillator
- AGRO 65.15
- COGT 78.62
About AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.